Literature DB >> 34265788

Severe Pain Profiles and Associated Sociodemographic and Clinical Characteristics in Individuals With Sickle Cell Disease.

Mitchell R Knisely1, Paula J Tanabe1,2, Qing Yang1, Rita Masese1, Meilin Jiang3, Nirmish R Shah1,2.   

Abstract

OBJECTIVE: The aim of this study was to identify classes of individuals with sickle cell disease (SCD) who share distinct severe pain profiles and evaluate differences in demographic, clinical, and psychosocial characteristics between classes.
METHODS: This exploratory, cross-sectional study used data collected for the SCD Implementation Consortium Research Registry at Duke University. Using Adult Sickle Cell Quality of Life-Measurement System pain-item data from 291 adults with SCD, latent class analysis was used to determine classes of individuals sharing distinct severe pain profiles. Bivariate analyses and logistic regression models were used to assess the relationships between pain profile classes and demographic, clinical, and psychosocial characteristics.
RESULTS: Three classes sharing distinct severe pain profiles were identified: Low Frequency and Impact class (n=73), Moderate Frequency and Impact class (n=94), and High Frequency and Impact class (n=124). When compared with the Low Frequency and Impact class and controlling for age and sex, individuals in the Moderate Frequency and Impact class were more likely to: be female (P=0.031) and unemployed (P=0.013); report worse sleep (P=0.005) and social functioning (P=0.005); have less emotional distress (P=0.004); describe pain as "sore" (P=0.002); and have previous SCD-related lung complications (P=0.016). When compared with the Low Frequency and Impact class, individuals in the High Frequency and Impact class: had worse social functioning (P<0.001) and previous SCD-related lung complications (P=0.006); described pain as "sore" (P<0.001); and were taking pain medication daily for SCD (P=0.001). DISCUSSION: Severe pain experiences in SCD are complex; however, there are subgroups of people who report similar experiences of severe pain.
Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2021        PMID: 34265788      PMCID: PMC8373671          DOI: 10.1097/AJP.0000000000000957

Source DB:  PubMed          Journal:  Clin J Pain        ISSN: 0749-8047            Impact factor:   3.423


  40 in total

Review 1.  Targeting pain at its source in sickle cell disease.

Authors:  Kanika Gupta; Om Jahagirdar; Kalpna Gupta
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2018-03-28       Impact factor: 3.619

2.  Item banks for measuring emotional distress from the Patient-Reported Outcomes Measurement Information System (PROMIS®): depression, anxiety, and anger.

Authors:  Paul A Pilkonis; Seung W Choi; Steven P Reise; Angela M Stover; William T Riley; David Cella
Journal:  Assessment       Date:  2011-06-21

3.  Patient-reported outcomes: descriptors of nociceptive and neuropathic pain and barriers to effective pain management in adult outpatients with sickle cell disease.

Authors:  Diana J Wilkie; Robert Molokie; Debra Boyd-Seal; Marie L Suarez; Young Ok Kim; Shiping Zong; Harriet Wittert; Zhongsheng Zhao; Yogen Saunthararajah; Zaijie J Wang
Journal:  J Natl Med Assoc       Date:  2010-01       Impact factor: 1.798

4.  Causes and outcomes of the acute chest syndrome in sickle cell disease. National Acute Chest Syndrome Study Group.

Authors:  E P Vichinsky; L D Neumayr; A N Earles; R Williams; E T Lennette; D Dean; B Nickerson; E Orringer; V McKie; R Bellevue; C Daeschner; E A Manci
Journal:  N Engl J Med       Date:  2000-06-22       Impact factor: 91.245

5.  Neuro-QOL: brief measures of health-related quality of life for clinical research in neurology.

Authors:  D Cella; J-S Lai; C J Nowinski; D Victorson; A Peterman; D Miller; F Bethoux; A Heinemann; S Rubin; J E Cavazos; A T Reder; R Sufit; T Simuni; G L Holmes; A Siderowf; V Wojna; R Bode; N McKinney; T Podrabsky; K Wortman; S Choi; R Gershon; N Rothrock; C Moy
Journal:  Neurology       Date:  2012-05-09       Impact factor: 9.910

6.  Patient reports of health outcome for adults living with sickle cell disease: development and testing of the ASCQ-Me item banks.

Authors:  San D Keller; Manshu Yang; Marsha J Treadwell; Ellen M Werner; Kathryn L Hassell
Journal:  Health Qual Life Outcomes       Date:  2014-08-22       Impact factor: 3.186

7.  Sensitivity of alternative measures of functioning and wellbeing for adults with sickle cell disease: comparison of PROMIS® to ASCQ-Me℠.

Authors:  San Keller; Manshu Yang; Marsha J Treadwell; Kathryn L Hassell
Journal:  Health Qual Life Outcomes       Date:  2017-06-02       Impact factor: 3.186

8.  Comorbidity, Pain, Utilization, and Psychosocial Outcomes in Older versus Younger Sickle Cell Adults: The PiSCES Project.

Authors:  Donna K McClish; Wally R Smith; James L Levenson; Imoigele P Aisiku; John D Roberts; Susan D Roseff; Viktor E Bovbjerg
Journal:  Biomed Res Int       Date:  2017-03-28       Impact factor: 3.411

9.  Publication of data collection forms from NHLBI funded sickle cell disease implementation consortium (SCDIC) registry.

Authors:  Jeffrey A Glassberg; Elizabeth A Linton; Katrina Burson; Tabitha Hendershot; Joseph Telfair; Julie Kanter; Victor R Gordeuk; Allison A King; Cathy L Melvin; Nirmish Shah; Jane S Hankins; Axel Yannick Epié; Lynne D Richardson
Journal:  Orphanet J Rare Dis       Date:  2020-07-07       Impact factor: 4.123

10.  Preliminary evidence that hydroxyurea is associated with attenuated peripheral sensitization in adults with sickle cell disease.

Authors:  Janelle E Letzen; Sophie Lanzkron; Kasey Bond; Christopher Patrick Carroll; Jennifer A Haythornthwaite; Sabrina Nance; Claudia M Campbell
Journal:  Pain Rep       Date:  2019-03-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.